Most Popular Stories
- Interview: Behind WellPoint's $1B primary care initiative
- Healthcare jobs will grow the fastest of all industries
- Hospitals criticized for patient data-mining
- Smartphone-powered monitoring to rise to 3 million users by 2016
- Young docs fuel palliative medicine, reveal generational differences
- Blues' Horizon invests $1M to train medical home care coordinators
Featured Jobs
-
Electronic Health Records Application Support Manager RN-New Year New Career
Avanti on behalf of Respected Health System - San Francisco, CA -
Epic Ambulatory Beacon Consultant
Meditology Services - NC -
ICD-10 Revenue Cycle, Manager
Meditology Services - Atlanta, GA
Events
- 3rd Healthcare IT Innovation Asia
Mar 14-15 2012 — Singapore - From IHI: The Patient Experience Seminar
March 27-28 — Boston, MA - IHI's Breakthrough Series College
April 11-13, 2012 — Cambridge, MA - CIO Healthcare Summit
March 11-14 — Scottsdale, AZ
Paid Research Reports
- Electronic health records: getting it right first time
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Stakeholder Opinions: Ophthalmology - Leading brands under threat
- Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
- Healthcare Regulatory Update: The United Arab Emirates
- Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
Despite risks, Pfizer seeks Celebrex use for kids
Drugmaker Pfizer is seeking permission to sell painkiller Celebrex to children as young as two years old with arthritis. According to the FDA, about 1 in 1,000 children have juvenile rheumatoid arthritis. Some physicians already prescribe Celebrex, given that other drugs make them sick to their stomach. Still, Pfizer's move is controversial, particularly given that critics are already calling for the drug's removal from the market. Celebrex is the last cox-2 inhibitor to remain on the market, and its continued use is drawing tremendous criticism given the well-documented cardiac complications generated by sister cox-2 inhibitor Vioxx. Notably, when a pediatric form of Vioxx was tested, the FDA received thousands of reports of serious side effects, particularly heart problems. Still, the FDA will meet this week to consider Pfizer's request.
Get more information on the application:
- read this Boston Globe article
Related Articles:
New warning on Celebrex. Report
Celebrex linked to heart attack risk. Report
Related Stories
- Drugmakers face direct-to-consumer ad ban
- Panel approves Celebrex for children
- Gilmartin testifies in Vioxx suit
- Study: Celebrex doubles heart attack risk
- MA anesthesiologist accused of fabricating 21 studies
- Studies raise questions about how much drug safety info should be released
- FL sues Merck over Vioxx marketing
- Merck agrees to $58M settlement on Vioxx ads
- Reports suggest that Merck downplayed Vioxx risks
- WellPoint, FDA collaborate on tracking drug safety
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map
| Editors | List in Marketplace | Supplier in MarketplaceTHE FIERCEMARKETS NETWORKFierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2011 FierceMarkets. All rights reserved. |
![]() |
